How can attrition rates be reduced in cancer drug discovery?

Author: Moreno Lucas   Pearson Andrew DJ  

Publisher: Informa Healthcare

ISSN: 1746-0441

Source: Expert Opinion on Drug Discovery, Vol.8, Iss.4, 2013-04, pp. : 363-368

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract